The Joint Committee on Vaccination and Immunization in the United Kingdom (JCVI) today recommended to the British authorities that, if possible, AstraZeneca’s covid-19 vaccine should not be given to people under 30 years of age, because it may be due to blood clots. Rare side effect brain.
Wei Shen Lim, chairman of JCVI covid-19, said that based on available data and evidence, the committee recommends that minors under 30 with health problems should best substitute the AstraZeneca vaccine.
He explained that for young people, the risk of hospitalization is much lower. Therefore, considering the risks and benefits of the AstraZeneca vaccine, it is best to use other vaccines.
“We do not recommend that anyone in any age group discontinue vaccination. We recommend that one vaccine for a certain age group be given priority over another. This is out of extreme caution, not because we are concerned about vaccines. There are serious concerns about the safety of the country,” he said. Sheet metal parts in the presentation.
He added that people should and should get a second dose of AstraZeneca vaccine.
After the British medical regulatory agency MHRA determined that the vaccine developed by Oxford and AstraZeneca might have side effects, the drug rarely clots in the brain, so the recommendation was issued.
MHRA executive director June Raine emphasized that the benefits of this vaccine outweigh the risks for most people, as did the European Medicines Agency’s latest opinion on Wednesday.
Today, the European Regulatory Agency (EMA) announced that it has established a link between the AstraZeneca vaccine and the formation of rare blood clots. She emphasized that the benefits of AstraZeneca still outweigh the risks of possible side effects.
>Video EMA: There is a link between AstraZeneca and abnormal blood clots
EMA executive director Emer Cooke said: “We concluded that the combination of abnormal blood clots and low platelets should be listed as a possible rare side effect of the vaccine.”